Skip to main content
Clinical Trials/NCT00203541
NCT00203541TerminatedNot Applicable

Effects of a New Antimicrobial Dressing on Wound Healing and Incidence of Sternal Wound Infections in Subjects Who Have Undergone Cardiac Surgical Procedures Requiring Median Sternotomy

Tyco Healthcare Group1 site in 1 country1,100 target enrollmentStarted: February 1, 2004Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
1,100
Locations
1
Primary Endpoint
Decreased cumulative incidence rate of superficial surgical site infections localized at the sternal incision in the treatment group as compared to the control group.

Study Overview

Brief Summary

The primary objective of this pivotal study is to determine if a new antimicrobial dressing, applied to the sternal incisions of cardiac surgical subjects, will demonstrate a decreased cumulative incidence rate(CI) of localized, superficial infections at the sternal incisional site as compared to the control group, regular, non-antimicrobial dressing.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
Double

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Sign an informed consent form that has been approved by the Institutional Review Board.
  • •Adults at least 18 years of age.
  • •Be undergoing cardiopulmonary bypass surgery with a median sternotomy.
  • •Be able to return to the study site, if needed, to have the sternal surgical incision site inspected.

Exclusion Criteria

  • •Be participating concurrently in another clinical trial that involves an investigational drug or device that would interfere with this study.
  • •Be in need of a left ventricular assist device.
  • •Have an active pre-operative infectious process.
  • •Subject is to receive another topical antimicrobial agent (i.e., Dermabond® Topical Skin Adhesive) other than the study dressing (as assigned by the randomization schedule).

Outcomes

Primary Outcomes

Decreased cumulative incidence rate of superficial surgical site infections localized at the sternal incision in the treatment group as compared to the control group.

Secondary Outcomes

  • Reduction of microbial log counts at the incisional site in the treatment group compared to the control group; Decreased cumulative incidence of mediastinitis in the treatment group as compared to the control group

Investigators

Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials